Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses
Titel:
Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses
Auteur:
Mitchell, P. Thatcher, N. Socinski, M.A. Wasilewska-Tesluk, E. Horwood, K. Szczesna, A. MartÃn, C. Ragulin, Y. Zukin, M. Helwig, C. Falk, M. Butts, C. Shepherd, F.A.